Longitudinal Assessment of Solid Organ Transplant Recipients with SARS-CoV-2 Infection
Authors:
- Will VuykWVWill Vuyk
- Max BobholzMBMax Bobholz
- Isla EmmenIEIsla Emmen
- Andrew J LailALAndrew J Lail
- Nicholas R MinorNMNicholas R Minor
- Jens C. EickhoffJEJens C. Eickhoff
- Hunter J. RiesHRHunter J. Ries
- Heather MachkovechHMHeather Machkovech
- Wanting WeiWWWanting Wei
- Andrea WeilerAWAndrea Weiler
- Alex RichardsonARAlex Richardson
Preprint
Abstract
Background: Compared to immunocompetent individuals, those who are immunocompromised, including solid organ transplant (SOT) recipients, have higher SARS-CoV-2-related morbidity and mortality. We determined the duration of SARS-CoV-2 RNA positivity to evaluate viral persistence in SOT recipients. Methods: This study prospectively followed SOT recipients who recently tested positive for SARS-CoV-2. The duration of viral RNA shedding in nasal swabs and stool samples was tracked, and viral genome sequencing was performed where possible. Persistent infection was defined as a positive nucleic acid amplification test (NAAT) for SARS-CoV-2 at 28 days or later after initial infection. This duration was chosen based on the CDC recommendation that immunocompromised individuals isolate for at least 20 days 1 , compared to 10 days for non-immunocompromised individuals. Results: Of 30 SOT recipients, 12 (40%) had SARS-CoV-2 RNA in nasal swabs or stool 28 or more days after the first positive SARS-CoV-2 test. IC-015 had high viral loads (Ct1 , compared to 10 days for non-immunocompromised individuals. In 12 of 30 SOT subjects, SARS-CoV-2 RNA was detected at or beyond 28 days post-detection (dpd), despite vaccination and antibody and/or antiviral treatment in most participants. Three subjects tested positive for SARS-CoV-2 RNA past 50 dpd. The CDC recommendation for 20 days of isolation may be insufficient for SOT recipients. Viral persistence in the setting of host immune suppression, coupled with exposure to antiviral treatments, raises concern about the selection of unusual viral variants. VisualKeywords
All Related Versions
- Published version: Transplantation Proceedings, 57 (5), 922.
This publication has 26 references indexed in Scilit:
- Prevalence of persistent SARS-CoV-2 in a large community surveillance studyNature, 2024
- SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysisThe Lancet Microbe, 2024
- Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM studyThe Lancet Regional Health - Europe, 2023
- SARS-CoV-2 infection in HIV-infected patients: potential role in the high mutational load of the Omicron variant emerging in South AfricaGeroScience, 2022
- COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patientsJournal of Infection, 2021
- COVID-19 and comorbidities: Deleterious impact on infected patientsJournal of Infection and Public Health, 2020
- First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the communityScience of The Total Environment, 2020
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiologyNature Microbiology, 2020
- COVID-19 and the elderly: insights into pathogenesis and clinical decision-makingAging Clinical and Experimental Research, 2020
- The nf-core framework for community-curated bioinformatics pipelinesNature Biotechnology, 2020